PharmaShots

FEBRUARY 22, 2023

In 2021, the revenue of Trulicity increased by 28% in the U.S., In the US, Trulicity is protected by a compound patent (2027) and by biologics data protection (2026). Active Ingredient: dulaglutide Dosage Forms & Strengths: Injection: 0.75 mL, 3 mg/0.5 It is one of the key growth products of Eli Lilly.

Diabetes 64

Diabetes Compounding Dosage Communication 64

Pharmaceutical Technology

OCTOBER 28, 2022

GlobalData’s Smart Pharma 2021 Survey found that 22% of industry professionals thought robotics would be one of the most disruptive technologies for optimising the drug discovery and development process. Robots can improve drug discovery and development.

Compounding 124

Compounding 124

Express Pharma

SEPTEMBER 19, 2023

billion in 2021 and is projected to reach $536.01 billion by 2029 at a compounded annual growth rate (CAGR) of 8.2 per cent from 2021 to 2030. The high prevalence of breast cancer, ovarian cancer, pancreatic cancer and cancers of the lung and intestine is a key driver of the global oncology market, which was valued at $286.04

Chemotherapy 105

Chemotherapy Compounding 105

pharmaphorum

NOVEMBER 27, 2020

Given these circumstances, drug repositioning and repurposing has appeared as an alternative tool to accelerate drug development processes by seeking new indications for approved/shelved drugs rather than discovering de novo drug compounds. The post AI Driven Repositioning and Repurposing Summit 2021 appeared first on.

Drug Development 52

Drug Development Compounding 52

Express Pharma

MARCH 25, 2025

The global cell and gene therapy (CGT) market is poised for exceptional growth at a compound annual growth rate of 44 per cent, with sales projected to rise from $8.70 billion in 2024 to $76.03 billion in 2030.

Compounding 63

Compounding 63

RX Note

JUNE 8, 2025

External Links APF and Handbook 25th Edition, 2021 Therapeutic Guidelines FAQ Expiry dates guidance aligned with the United States Pharmacopeia. Currently, a single, consolidated national drug formulary encompassing all drugs legally available for use across both public and private sectors does not exist in Malaysia.

Compounding 40

Compounding Hospitals Patient Counseling Labelling 40

pharmaphorum

JULY 8, 2022

The number of AI-based drug discovery strategic alliances has increased significantly, from just 10 in 2015 to 105 in 2021, with companies like BenevolentAI, Exscientia and Insilico Medicine featuring prominently in the dealmaking.

Compounding 131

Compounding 131

pharmaphorum

AUGUST 2, 2022

This potential sees a number of positions in the top 10 blockbusters of 2021 being occupied by mAbs. The potential for ADCs to combine the best of both mAbs and small molecule drugs means that there has been high interest in developing a successful compound since the first successful clinical trial in 1983. Not all rosy.

Compounding 98

Compounding Drug Development 98

Pharmaceutical Technology

SEPTEMBER 15, 2022

The top 13 players reported more than 10% revenue growth, with BioNTech (3,834.4%), Moderna (2,199.1%), Pfizer (95.2%) and Regeneron Pharmaceuticals (89.1%) reporting a more than 80% year-on-year (YoY) revenue growth from 2020 to 2021, according to GlobalData’s Pharma Intelligence Centre Companies Database. AbbVie reported a 22.7%

Vaccines 108

Vaccines Drug Pricing Documentation Biosimilars 108

pharmaphorum

MARCH 24, 2022

GlaxoSmithKline has thrown its financial and drug development weight behind LifeMine Therapeutics, a US startup that aims to find new therapeutics from fungi – widely regarded as an underexplored resource of biologically-active compounds. Image by jggrz from Pixabay .

Compounding 105

Compounding Immunity Immunization Drug Development 105

pharmaphorum

NOVEMBER 3, 2021

The 2021 Veeva Pulse Content Metrics Report provides information on how current digital trends impact the commercial content landscape and how Veeva utilises these trends to improve brand engagement. Digital content can then be approved quicker without jeopardising content compliant delivery.

Compounding 98

Compounding Communication Pharmaceutical Companies Pharmaceutical Companies 98

European Pharmaceutical Review

OCTOBER 7, 2022

billion by 2030, displaying a compound annual growth rate (CAGR) of 6.0 Tablets were noted to be the most common form of OSD in 2021 because of their convenience and simplicity in production, transportation and delivery to the end user. This is especially beneficial as a way of decreasing potential side effects.

Dosage 98

Dosage Compounding Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

NOVEMBER 24, 2020

The merger is expected to be completed in the first quarter of 2021, subject to the usual closing conditions. Once completed, UpHealth will continue to be listed on the NYSE but with a new ticker symbol (UPH).

Packaging 138

Packaging Compounding 138

BioPharma Dive

JULY 9, 2025

M Ventures, which helped found the company in 2021, co-led the Series A round with Hadean Ventures, Sofinnova Partners and 4BIO Capital. The technology works by attaching a radioisotope to a targeting compound via a specially engineered “linker” molecule. Five other firms also participated.

Drug Pricing 52

Drug Pricing Compounding Immunity Immunization 52

European Pharmaceutical Review

DECEMBER 21, 2022

Although some psychedelics have a long history in traditional medicine, regulatory agencies must evaluate psychedelic compounds the same way they assess any other drug. Psychedelic compounds are assessed by regulators the same way as any other drug. Expediated pathways available for psychedelics.

Compounding 119

Compounding Controlled Substances Drug Development 119

pharmaphorum

MARCH 2, 2022

The term ‘psychedelic treatments’ incorporates a broad spectrum of different compounds, from LSD, psilocybin and DMT, to MDMA, ibogaine and ketamine. The latter compound has already been approved for treatment-resistance depression as the product Spravato (esketamine), after being developed by Janssen. Paving the way to patients.

Compounding 105

Compounding Drug Development 105

European Pharmaceutical Review

FEBRUARY 8, 2023

Research from data and analytics company GlobalData shows that the use of CD19 chimeric antigen receptor T-cell (CAR-T) agents for blood cancer is set to significantly increase between 2021-2031. Breyanzi will exhibit the largest compound annual growth rate (CAGR) at 30 percent, compared to Yescarta’s CAGR of 9 percent.

Labelling 98

Labelling Compounding 98

European Pharmaceutical Review

FEBRUARY 6, 2023

The compound is in development for immunology and inflammation indications. In May 2021, Bristol Myers Squibb and Exscientia expanded the collaboration in immunology & inflammation indications and oncology. The post BMS in-licensed PKC theta inhibitor enters clinical trials appeared first on European Pharmaceutical Review.

Compounding 98

Compounding Immunity Immunization 98

Pharmaceutical Technology

JANUARY 2, 2024

The age-related macular degeneration (AMD) market is expected to grow at a compound annual growth rate of 14.1%

Compounding 59

Compounding 59

RX Note

APRIL 16, 2023

Compounding Sterile Preparations, 2018 Guide to the Development of Sterile Pharmaceutical Preparation Facilities, 2010 NOTE: Best refer PIC/S for the updated info. Manual for Sterile Preparations, 2021 NOTE: May refer PIC/S for more info.

Compounding 52

Compounding 52

European Pharmaceutical Review

SEPTEMBER 15, 2023

Promisingly, Caliway also shared that according to the Global Dercum’s Disease Market Research Report, the global Dercum’s disease treatment market size in 2021 was $11.3 With a compound annual growth rate (CAGR) of 6.76 percent, the global market of Dercum’s disease treatment in 2030 is predicted to grow to $19.95

Compounding 119

Compounding 119

pharmaphorum

AUGUST 17, 2022

The deal will see Atomwise identify, synthesize, and advance lead compounds for up to five drug targets that will then be exclusively Sanofi’s to develop. That same report noted that the number of companies in the AI drug discovery space increased tenfold between 2015 and 2021.

Compounding 97

Compounding Drug Development 97

European Pharmaceutical Review

DECEMBER 9, 2022

The research projected a compound annual growth rate (CAGR) of 16.8 According to the report data, in 2021, antisense oligos accounted for the largest share of this segment, since many of these therapies are currently in clinical trials. percent from $7.7 billion in 2022. Synthesised oligonucleotides.

Compounding 98

Compounding 98

European Pharmaceutical Review

AUGUST 19, 2022

percent compound annual growth rate (CAGR) of the market include the increasing commercialisation of generics and emerging technologies and small biotechs with limited or no production capabilities driving development in the biopharmaceutical sector. percent between 2021 and 2026 (the forecast period). billion in 2021.

Packaging 98

Packaging Compounding 98

European Pharmaceutical Review

OCTOBER 6, 2022

billion in 2032, propelled by a compound annual growth rate (CAGR) of 11.3 percent, led primarily by the rapid advancement of technology, In 2021, the market share for bacterial identification systems was 28.4 percent share of the North American market in 2021. In 2021, these techniques held a revenue share of 58.7

Compounding 98

Compounding Drug Development 98

Express Pharma

NOVEMBER 8, 2023

The market for myasthenia gravis (MG), an autoimmune and neuromuscular disease characterised by muscle weakness and fatigue, is set to experience a compound annual growth rate (CARG) of 8.3 Vyvgart was approved for the use in the US in 2021 and in Europe and Japan in 2022, while Ultomiris was approved in 2022 across the whole 7MM.

Labelling 105

Labelling Compounding 105

Pharmacy Joe

OCTOBER 25, 2023

The removal appears to be in response to the publication of a 2021 article in the International Journal of Pharmaceutical Compounding. .” How is this possible when we all have referred to this list as the “ISMP’s Do Not Crush List” for over a decade?

Dosage 111

Dosage Inpatient Packaging Documentation 111

pharmaphorum

JANUARY 11, 2023

Anima uses its mRNA Lightning platform to discover small molecules and determine their mechanisms of action for diseases previously deemed undruggable, with scientists searching for compounds that target proteins with roles in regulating mRNA, so as to affect disease states through post-transcriptional regulation (i.e.

Compounding 105

Compounding 105

European Pharmaceutical Review

JULY 13, 2023

While this is essential in the interrogation of novel compounds for which we know very little about their efficacy and safety, it is also true that some biomedical research is highly wasteful. 3 Moreover, some studies have suggested that co-administration of these compounds can modulate the effects of one another at a receptor level.

Compounding 98

Compounding Drug Development Clinical Pharmacology Documentation 98

pharmaphorum

AUGUST 11, 2020

A phase 3 trial is expected to begin in 2021 and the company says that the compound could generate peak sales of more than a billion euros globally. At the beginning of this year, KaNDy completed a phase 2b trial of its first-in-class drug NT-814, showing activity against symptoms of the menopause such as hot flashes and night sweats.

Compounding 98

Compounding 98

pharmaphorum

OCTOBER 2, 2020

Phase 1 first-in-man pharmacokinetic studies are expected to start in Q4 2021. Including an $80 million series B round in April, Compass had already raised more than $100 million to fund research into the compound, which is being developed for treatment resistant depression, a subset of patients with major depressive disorder.

Compounding 122

Compounding 122

Pharmaceutical Business Review

AUGUST 16, 2024

This move comes as part of the research collaboration agreement initiated on 21 December 2021. As per the 2021 deal, Aarvik carried out the discovery and preclinical development process of a new antibody drug conjugate (ADC) molecule that depends on the modular platform of Aarvik.

Compounding 59

Compounding Drug Development 59

European Pharmaceutical Review

OCTOBER 21, 2022

1 In their pharmaceutical application they are used as molecular containers (hosts) that can form inclusion complexes with drug compounds, according to the equilibrium for a 1:1 system: CD + compound ? CD-compound (1). CD – compound]. _ (2). [CD]?[compound].

Compounding 72

Compounding 72

Express Pharma

JUNE 5, 2023

billion in 2021 to $2.89 billion in 2031 across the 8MM, registering a compound annual growth rate (CAGR) of 1.9 GlobalData’s latest report, ‘Myelofibrosis: Eight-Market Drug Forecast and Market Analysis,’ reveals that the MF market will grow from $2.39 per cent, driven by the approvals of nine pipeline agents.

Drug Development 97

Drug Development Biosimilars Compounding 97

pharmaphorum

AUGUST 7, 2020

Denali has been working on small-molecule compounds capable of crossing the blood-brain barrier and Biogen has bought a licence to co-develop and co-market compounds known as LRRK2 inhibitors in Parkinson’s disease. Mutations in the LRRK2 gene can cause Parkinson’s disease.

Compounding 69

Compounding 69

pharmaphorum

OCTOBER 21, 2021

. — British Porphyria Association (@BPA_Porphyria) October 21, 2021. Givlaari works by RNA interference to suppress the activity of an enzyme in the liver that is involved in the production of compounds called porphyrins in the body, that cause toxicity when present in high concentrations.

Documentation 98

Documentation Compounding Hospitals 98

Express Pharma

AUGUST 17, 2023

million in 2021. Globally, the systemic antibacterial market, which is growing at a compounded annual growth rate of 4.26 per cent of K. pneumoniae isolates from Oman are multi-drug resistant and produce ESBL against which Elores exhibits remarkable efficacy. The Oman antibiotics market is primarily dependent on imports from India.

Compounding 98

Compounding 98